VREX · Varex Imaging Corp
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Cash flow from operations | $21M | Q3FY26 | — |
| Industrial gross margin | 37.1% | the three months ended July 3, 2026 filing | — |
| Non-GAAP diluted net income per share non-GAAP | $0.71 | Nine Months Ended July 3, 2026 | — |
| Non-GAAP gross margin non-GAAP | 34.7% | Nine Months Ended July 3, 2026 | — |
| Non-GAAP operating margin non-GAAP | 11.6% | Three Months Ended July 3, 2026 | — |
| Research and development as a percentage of total revenues, net | 11.1% | the three months ended July 3, 2026 filing | — |
| Selling, general, and administrative as a percentage of total revenues, net | 14.5% | the three months ended July 3, 2026 filing | — |
| Total gross margin | 36.4% | the three months ended July 3, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VREX
this stock
Varex Imaging Corp
|
$776.75M | +58.5% | -9.2% | 35.5 | 3.3% |
|
ABT
Abbott Laboratories
|
$174.90B | -22.2% | +5.7% | 28.1 | 1.1% |
|
MDT
Medtronic plc
|
$113.38B | -10.1% | +8.4% | 21.8 | 1.3% |
|
SYK
Stryker Corp
|
$104.47B | -21.6% | +11.2% | 28.2 | 2.0% |
|
BSX
Boston Scientific Corp
|
$63.59B | -55.3% | +12.5% | 17.8 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VREX | +0.1% | -0.3% | +61.7% | +0.1% | +58.5% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | +0.3% | +0.1% | +49.5% | -0.9% | +45.6% |